Compile Data Set for Download or QSAR
maximum 50k data
Found 8 of ec50 data for polymerid = 50001912,50005670
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241754(CHEMBL4077894)
Affinity DataEC50:  1.96E+4nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241756(CHEMBL4075879)
Affinity DataEC50:  3.05E+4nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241781(CHEMBL4066833)
Affinity DataEC50:  3.95E+4nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241780(CHEMBL4105269)
Affinity DataEC50:  8.28E+4nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241778(CHEMBL4086672)
Affinity DataEC50:  9.70E+4nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241757(CHEMBL4066786)
Affinity DataEC50:  1.05E+5nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241782(CHEMBL4081207)
Affinity DataEC50:  1.16E+5nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241779(CHEMBL4082159)
Affinity DataEC50:  1.37E+5nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed